TrialLeukemia2020

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy.

Fabio Efficace et al.PubMed ↗Publisher ↗

No numbers read from the abstract.